Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients

Autor: Mannil, M., Solari, A., Leha, A., Pelayo-Negro, A. L., Berciano, J., Schlotter-Weigel, B., Walter, M. C., Rautenstrauss, B., Schnizer, T. J., Schenone, A., Seeman, P., Kadian, C., Schreiber, O., Angarita, N. G., Fabrizi, G. M., Gemignani, F., Padua, L., Santoro, L., Quattrone, A., Vita, G., Calabrese, D., Marchesi, C., Salsano, E., Nanetti, L., Marelli, C., Scaioli, V., Ciano, C., Rimoldi, M., Lauria, G., Rizzetto, E., Camozzi, F., Narciso, E., Grandis, M., Monti-Bragadin, M., Nobbio, L., Cavallaro, T., Casano, A., Bertolasi, L., Cabrini, I., Corra, K., Manganelli, F., Pisciotta, C., Nolano, M., Mazzeo, A., Aguennouz, M., Di Leo, R., Majorana, G., Lanzano, N., Valenti, F., Valentino, P., Nistico, R., Pirritano, D., Lucisano, A., Canino, M., Pazzaglia, C., Granata, G., Foschini, M., Brindani, F., Vitetta, F., Allegri, I., Visioli, F., Bogani, P., Blake, J., Koltzenburg, M., Hutton, E., Lunn, M., Young, P., Laura, M., Haberlova, J., Mazanec, R., Paulus, W., Beissbarth, T., Shy, M. E., Reilly, M. M., Pareyson, D., Sereda, M. W.

Publikováno v: Neuromuscular disorders 24 (2014): 1003–1017. doi:10.1016/j.nmd.2014.06.431
info:cnr-pdr/source/autori:Mannil, Manoj; Solari, Alessandra; Leha, Andreas; Pelayo-Negro, Ana L.; Berciano, Jose; Schlotter-Weigel, Beate; Walter, Maggie C.; Rautenstrauss, Bernd; Schnizer, Tuuli J.; Schenone, Angelo; Seeman, Pavel; Kadian, Chandini; Schreiber, Olivia; Angarita, Natalia G.; Fabrizi, Gian Maria; Gemignani, Franco; Padua, Luca; Santoro, Lucio; Quattrone, Aldo; Vita, Giuseppe; Calabrese, Daniela; Young, Peter; Laura, Matilde; Haberlova, Jana; Mazanec, Radim; Paulus, Walter; Beissbarth, Tim; Shy, Michael E.; Reilly, Mary M.; Pareyson, Davide; Sereda, Michael W./titolo:Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients/doi:10.1016%2Fj.nmd.2014.06.431/rivista:Neuromuscular disorders/anno:2014/pagina_da:1003/pagina_a:1017/intervallo_pagine:1003–1017/volume:24

This study evaluates primary and secondary clinical outcome measures in Charcot-Marie-Tooth disease type 1A (CMT1A) with regard to their contribution towards discrimination of disease severity. The nine components of the composite Charcot-Marie-Tooth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeda0250e6c2131c9873e1f957a473d4
http://hdl.handle.net/10807/62378

BIOMARKERS IN CHARCOT-MARIE-TOOTH DISEASE 1A

Autor: Fledrich, R., Mannil, M., Leha, A., Solari, A., Pelayo-Negro, A. L., Berciano, J., Schlotter-Weigel, B., Schnizer, T. J., Angarita, N. G., Haberlova, J., Mazanec, R., Paulus, Walter, Beissbarth, T., Walter, M. C., Hogrel, J. Y., Dubourg, O., Schenone, A., Baets, J., Jonghe, P., Shy, M. E., Horvath, R., Davide Pareyson, Seeman, P., Young, P., Sereda, M. W.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0bc55571fc0bc660f86dba142e064a33
https://publons.com/wos-op/publon/11189760/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.